长风药业股份有限公司（02652）于2026年2月13日公告，已回购普通股合计27,500股，占回购前已发行股份总数（不包括库藏股）约0.0091%。回购价格每股介乎港币34.7元至35.2元，涉资约港币96.249万。
公司披露，截至上述回购完成后，其已发行股份总数仍为302,223,586股，其中不包括库藏股的已发行股份数为301,941,586股，库藏股数则由254,500股增至282,000股。本次回购基于2025年12月16日通过的购回授权，该授权可供回购股份总数为30,222,358股，公司至今已购回282,000股。
公告同时确认，公司在本次回购过程中严格遵守相关上市规则及适用法律。公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.